Academic Calendar-B. Pharm - 2025-2026 Click here B.Pharm.Management Quota / NRI Sponsored Seats Admission Year: 2025-2026 Click here
Academic Calendar-B. Pharm - 2025-2026 Click here B.Pharm.Management Quota / NRI Sponsored Seats Admission Year: 2025-2026 Click here
Quick Links
Mr.Maulik Gandhi
Education Qualification
Bachelor of Pharmacy
Master of Pharmacy (Pharmacology)
Designation
Experience
Department
Research Area
Screening of Transient Receptor Potential Vannilloid-1 (TRPV1), TRPV3 & TRPA1 antagonists for indication of
pain
● Executing screening (Invivo) NCE of:
o CFA induced thermal (Hargreave’s method) hyperalgesia
o CFA induced mechanical (Randall selitto method) hyperalgesia
o Capsaicin induced hypothermia
● Investigated NCE’s in model of osteoarthritis (Monosodium iodoacetate induced osteoarthritis in rats)
● Tested antagonists in pSNL, CCI, SNL and Formalin paw licking pain models
● Performing exvivo screening of these NCE using capsaicin induced rat urinary bladder contraction
Investigation of PDE4, RORγt and NLRP3 inhibitors for potential effects in rheumatoid arthritis, inflammatory and
neuropathic pain
● Developing animal models of arthritis:
o Collagen Induced Arthritis (CIA) in male DBA1/J mice and female Lewis rats
o Adjuvant induced arthritis model in female Lewis rats
o Carrageenan induced air pouch model of inflammation
Investigation of NLRP3 Inhibitors in EAE model of Multiple Sclerosis
● Developing EAE model of Multiple Sclerosis:
o Standardisation and Validation of Experimental Autoimmune Encephalomyelitis in C57BL/6J mice
o Cytokine estimation in spinal cord of EAE mice by ELISA
o Flow cytometric analysis of T cell infiltration in spinal cord of EAE mice
Screening of cannabinoid 2 (CB2) agonists for the indication of pain
● Screening NCE’s (Invitro) by receptor binding assay in rat and mouse spleen membrane for its affinity towards CB2
receptor
● Investigating activity of NCE using various inflammatory and neuropathic pain models like CFA and CCI induced
mechanical hyperalgesia in rats
● Evaluating activities in CIA and carrageenan air pouch models
Investigation of RORγt inhibitors for potential effects in chronic obstructive pulmonary disease
● Developing animal models of COPD:
o Viral COPD exacerbation: CS + Poly IC induced COPD exacerbation in female C57BL/6J mice
o Acute cigarette smoke induced pulmonary inflammation in female C57BL/6J mice
o LPS induced pulmonary inflammation in female Balb/c mice and female SD rats
o Anti-CD3 antibody induced IL-17 in male C57BL/6J mice
Screening of PDE10A inhibitors for Schizophrenia
● Spearheading:
o Apomorphine induced hypothermia in mice
o Apomorphine induced climbing behaviour in mice
o Apomorphine induced stereotypic behaviour in rats
o Quipazine induced head twitches in rats
o MK 801 induced psychosis behaviour in rats
o Assessment of cataleptic behaviour in rats
o Conditioned Avoidance Response in rats
o cGMP and cAMP estimation in striatum and hippocampus regions of rat brain
Biomarker Estimation and ELISA Assays
● Managing:
o IL-1β estimation in paw tissue of arthritic mice and rats
o IL-17 estimation in paw tissue of arthritic mice and rats
Safety Pharmacological Studies
Testing the NCE’s in various safety pharmacological model
● Rota rod test in rats
● Change in rectal temperature of rats and mice
● Tail flick test for rats and mice
● Hot plate test for mice
Profile
Development & Validation of Syngeneic CT26 Model in Balb/c mice.
o Flow cytometry characterization of CT26 model
o Estimation of IL-2 & IFN-γ in tumor tissue in CT26 Model by ELISA
o Screening & Evaluation of NCEs in CT26 Tumor Model.